Found 0 matching trials
Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)
PHASE3Data from this study are expected to demonstrate that V501 (Human Papilloma...
Location
Multiple Locations
A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)
PHASE2The purpose of this study is to evaluate vaccine immunogenicity and how wel...
Location
Multiple Locations
Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)
PHASE3A study to test the safety and effectiveness of Quadrivalent HPV (types 6, ...
Location
Multiple Locations
Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005)
PHASE2Subjects received HPV 16 L1 VLP vaccine or placebo (1:1 ratio). Endpoints i...
Location
Multiple Locations
Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002)
PHASE1This study will examine the safety and tolerability of octavalent Human Pap...
Location
Multiple Locations
A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)
PHASE3This study was conducted to assess the safety, immunogenicity, efficacy and...
Location
Multiple Locations
Phase 3 Trial of a Bivalent Human Papilloma Virus (HPV) Vaccine (CecolinĀ®) in Young Girls
PHASE3This randomized controlled trial will evaluate a bivalent HPV vaccine, Ceco...
Location
International Centre for Diarrhoeal Disease Research